APS and aPL persistent positivity without APS are frequent in hemodialysis (HD) patients, and have been associated with HD vascular access complications such as arteriovenous fistula (AVF) thrombosis, stenosis and maturation failure, as well as intrastent restenosis [16,17,18,19,20]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.